HIV-Related Cancers:@0.719697:0.035749:0.914545:0.035749:0.914545:0.019993:0.719697:0.019993:0.013143:0.004349:0.013508:0.006388:0.011680:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466
TREATMENT APPROACHES:@0.983689:0.278245:0.983689:0.065272:0.955679:0.065272:0.955679:0.278245:0.000000:0.000000:0.000000:0.057096:-0.123230:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.375913
133:@0.950254:0.038184:0.981863:0.038184:0.981863:0.018587:0.950254:0.018587:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.679047:0.970015:0.915156:0.970015:0.915156:0.956010:0.679047:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Outcomes:@0.084242:0.096122:0.192000:0.096122:0.192000:0.078100:0.084242:0.078100:0.017960:0.012828:0.006414:0.013683:0.013683:0.020098:0.013683:0.009407
Data are lacking from both Western and :@0.084242:0.113649:0.480492:0.113649:0.480492:0.097893:0.084242:0.097893:0.014316:0.013143:0.006523:0.013143:0.007639:0.013143:0.005715:0.012508:0.007639:0.003848:0.013143:0.012450:0.009660:0.003848:0.011738:0.012950:0.007639:0.006042:0.005711:0.012604:0.018049:0.007639:0.013123:0.012604:0.006523:0.011738:0.007639:0.017570:0.012508:0.007466:0.006523:0.012508:0.006188:0.011738:0.007639:0.013143:0.011738:0.013181:0.005330
LMICs owing to HIV-positive patients not :@0.084242:0.130027:0.480520:0.130027:0.480520:0.114271:0.084242:0.114271:0.008890:0.017684:0.004349:0.015644:0.007466:0.009390:0.012604:0.015990:0.003848:0.011738:0.012950:0.009390:0.006523:0.012604:0.009390:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.009390:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009390:0.011738:0.012604:0.006523:0.005330
being included in clinical trials in the West, :@0.084242:0.146405:0.480492:0.146405:0.480492:0.130649:0.084242:0.130649:0.013123:0.012508:0.003848:0.011738:0.012950:0.005311:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.013181:0.005311:0.003848:0.011738:0.005311:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005311:0.006523:0.005792:0.003848:0.013143:0.003848:0.007466:0.005311:0.003848:0.011738:0.005311:0.006523:0.011738:0.012508:0.005299:0.017570:0.012508:0.007466:0.006523:0.005330:0.005330
and poor reporting generally. Some stud-:@0.084242:0.162783:0.475167:0.162783:0.475167:0.147027:0.084242:0.147027:0.013143:0.011738:0.013181:0.006793:0.013123:0.012604:0.012604:0.005792:0.006793:0.005711:0.012508:0.013123:0.012604:0.005792:0.006523:0.003848:0.011738:0.012950:0.006793:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.003848:0.010314:0.005330:0.006793:0.009583:0.012604:0.018049:0.012508:0.006793:0.007466:0.006523:0.011699:0.013181:0.006388
ies have shown poor  treatment comple-:@0.084242:0.179451:0.475156:0.179451:0.475156:0.163695:0.084242:0.163695:0.003848:0.012508:0.007466:0.008640:0.011738:0.013143:0.010660:0.012508:0.008640:0.007466:0.011738:0.012604:0.015990:0.011738:0.008640:0.013123:0.012604:0.012604:0.005792:0.005330:0.003300:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.008640:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006388
tion rates and resultant poor outcomes in :@0.084242:0.196120:0.480490:0.196120:0.480490:0.180364:0.084242:0.180364:0.006523:0.003848:0.012604:0.011738:0.006658:0.005792:0.013143:0.006523:0.012508:0.007466:0.006658:0.013143:0.011738:0.013181:0.006658:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.013143:0.011738:0.006523:0.006658:0.013123:0.012604:0.012604:0.005792:0.006658:0.012604:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.007466:0.006648:0.003848:0.011738:0.005330
HIV-positive :@0.084242:0.212789:0.197542:0.212789:0.197542:0.197033:0.084242:0.197033:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330
versus:@0.200851:0.212789:0.256443:0.212789:0.256443:0.197033:0.200851:0.197033:0.010660:0.012508:0.005792:0.007466:0.011699:0.007466
 HIV-negative patients. :@0.256443:0.212789:0.480482:0.212789:0.480482:0.197033:0.256443:0.197033:0.008621:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.008621:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.005330
However,  in  sub-Saharan  Africa  regions :@0.084242:0.229458:0.480490:0.229458:0.480490:0.213702:0.084242:0.213702:0.013143:0.012604:0.015990:0.012508:0.010660:0.012508:0.003768:0.005330:0.005330:0.007047:0.003848:0.011738:0.005330:0.007052:0.007466:0.011699:0.013123:0.006388:0.009583:0.013143:0.011738:0.013143:0.005792:0.013143:0.011738:0.005330:0.007052:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.007052:0.005713:0.012508:0.012950:0.003848:0.012604:0.011738:0.007466:0.005330
where there were good  resources, out-:@0.084242:0.246126:0.475152:0.246126:0.475152:0.230370:0.084242:0.230370:0.015990:0.011738:0.012508:0.005709:0.012508:0.010968:0.006523:0.011738:0.012508:0.005705:0.012508:0.010968:0.015990:0.012508:0.005711:0.012508:0.010968:0.012950:0.012604:0.012604:0.013181:0.005330:0.005626:0.005713:0.012508:0.007466:0.012604:0.011699:0.005650:0.012450:0.012508:0.007466:0.005330:0.010968:0.012604:0.011699:0.006506:0.006388
comes were comparable stage for stage :@0.084242:0.262795:0.480488:0.262795:0.480488:0.247039:0.084242:0.247039:0.012450:0.012604:0.018049:0.012508:0.007466:0.006743:0.015990:0.012508:0.005711:0.012508:0.006744:0.012450:0.012604:0.018049:0.013123:0.013143:0.005792:0.013143:0.013123:0.003848:0.012508:0.006754:0.007466:0.006523:0.013143:0.012950:0.012508:0.006744:0.006042:0.012604:0.005792:0.006737:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330
and showed no difference in outcome by :@0.084242:0.279464:0.480505:0.279464:0.480505:0.263708:0.084242:0.263708:0.013143:0.011738:0.013181:0.005503:0.007466:0.011738:0.012604:0.015990:0.012508:0.013181:0.005503:0.011738:0.012604:0.005503:0.013181:0.003848:0.006102:0.006042:0.012508:0.005711:0.012508:0.011738:0.012450:0.012508:0.005492:0.003848:0.011738:0.005503:0.012604:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.005482:0.013123:0.010314:0.005330
HIV-status. Factors that contribute to out-:@0.084242:0.296133:0.475160:0.296133:0.475160:0.280377:0.084242:0.280377:0.013143:0.004349:0.013508:0.006388:0.007466:0.006523:0.013143:0.006523:0.011699:0.007466:0.005330:0.007408:0.009333:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.007397:0.006523:0.011738:0.013143:0.006523:0.007399:0.012450:0.012604:0.011738:0.006523:0.005792:0.003848:0.013123:0.011699:0.006523:0.012508:0.007389:0.006523:0.012604:0.007399:0.012604:0.011699:0.006523:0.006388
comes  include  total  radiation  dose,  the :@0.084242:0.312801:0.480486:0.312801:0.480486:0.297045:0.084242:0.297045:0.012450:0.012604:0.018049:0.012508:0.007466:0.005330:0.004718:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330:0.004722:0.006523:0.012604:0.006523:0.013143:0.003848:0.005330:0.004716:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.004722:0.013181:0.012604:0.007466:0.012508:0.005330:0.005330:0.004716:0.006523:0.011738:0.012508:0.005330
addition of chemotherapy and presenting :@0.084242:0.329470:0.480501:0.329470:0.480501:0.313714:0.084242:0.313714:0.013143:0.013181:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.004387:0.012604:0.006042:0.004387:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004387:0.013143:0.011738:0.013181:0.004387:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.003848:0.011738:0.012950:0.005330
haemoglobin levels.:@0.084242:0.346139:0.271894:0.346139:0.271894:0.330383:0.084242:0.330383:0.011738:0.013143:0.012508:0.018049:0.012604:0.012950:0.003848:0.012604:0.013123:0.003848:0.011738:0.005330:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466:0.005330
13:@0.271893:0.340603:0.284323:0.340603:0.284323:0.331417:0.271893:0.331417:0.006215:0.006215
CONCLUSION:@0.084242:0.380219:0.239464:0.380219:0.239464:0.360622:0.084242:0.360622:0.018344:0.019756:0.017404:0.018344:0.010348:0.015052:0.012230:0.006585:0.019756:0.017404
The  incidence  and  prevalence  of  HIV-:@0.084242:0.399188:0.475146:0.399188:0.475146:0.383432:0.084242:0.383432:0.008197:0.011738:0.012508:0.005330:0.007043:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005330:0.007052:0.013143:0.011738:0.013181:0.005330:0.007052:0.013123:0.005715:0.012508:0.010660:0.013143:0.003848:0.012508:0.011738:0.012450:0.012508:0.005330:0.007052:0.012604:0.006042:0.005330:0.007047:0.013143:0.004349:0.013508:0.006388
positive patients with cancer can be ex-:@0.084242:0.415856:0.475163:0.415856:0.475163:0.400100:0.084242:0.400100:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.008043:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008032:0.015990:0.003848:0.006523:0.011738:0.008030:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.008030:0.012450:0.013143:0.011738:0.008030:0.013123:0.012508:0.008030:0.012508:0.009236:0.006388
pected to increase with the extended :@0.084242:0.432525:0.480480:0.432525:0.480480:0.416769:0.084242:0.416769:0.013123:0.012508:0.012450:0.006523:0.012508:0.013181:0.012373:0.006523:0.012604:0.012373:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.012373:0.015990:0.003848:0.006523:0.011738:0.012373:0.006523:0.011738:0.012508:0.012373:0.012508:0.009236:0.006523:0.012508:0.011738:0.013181:0.012508:0.013181:0.005330
longevity of HIV-positive patients. In well-:@0.084242:0.449194:0.475144:0.449194:0.475144:0.433438:0.084242:0.433438:0.003848:0.012604:0.011738:0.012950:0.012508:0.010660:0.003848:0.006523:0.010314:0.008082:0.012604:0.006042:0.008082:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.008093:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.008082:0.004349:0.011738:0.008082:0.015990:0.012508:0.003848:0.003848:0.006388
resourced  settings  and in patients  where :@0.084242:0.465863:0.480495:0.465863:0.480495:0.450107:0.084242:0.450107:0.005713:0.012508:0.007466:0.012604:0.011699:0.005651:0.012450:0.012508:0.013181:0.005330:0.002896:0.007466:0.012508:0.006523:0.006523:0.003848:0.011738:0.012950:0.007466:0.005330:0.002894:0.013143:0.011738:0.013181:0.008236:0.003848:0.011738:0.008236:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.002896:0.015990:0.011738:0.012508:0.005709:0.012508:0.005330
general health is maintained, approaches :@0.084242:0.482531:0.480486:0.482531:0.480486:0.466775:0.084242:0.466775:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.004888:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.004888:0.003848:0.007466:0.004888:0.018049:0.013143:0.003848:0.011738:0.006523:0.013143:0.003848:0.011738:0.012508:0.013181:0.005330:0.004888:0.013143:0.013123:0.013123:0.005719:0.012604:0.013143:0.012450:0.011738:0.012508:0.007466:0.005330
to  HIV-positive patients  will mirror  that  of :@0.084242:0.499200:0.480484:0.499200:0.480484:0.483444:0.084242:0.483444:0.006523:0.012604:0.005330:0.003502:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.008852:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.003510:0.015990:0.003848:0.003848:0.003848:0.008852:0.018049:0.003848:0.005792:0.005711:0.012604:0.005792:0.005330:0.003500:0.006523:0.011738:0.013143:0.006523:0.005330:0.003502:0.012604:0.006042:0.005330
the  HIV-negative population.  The  impor-:@0.084242:0.515869:0.475160:0.515869:0.475160:0.500113:0.084242:0.500113:0.006523:0.011738:0.012508:0.005330:0.004428:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.009775:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.004432:0.008197:0.011738:0.012508:0.005330:0.004426:0.003848:0.018049:0.013123:0.012604:0.005792:0.006388
tance of risk reduction – reducing tobac-:@0.084242:0.532538:0.475183:0.532538:0.475183:0.516782:0.084242:0.516782:0.006523:0.013143:0.011738:0.012450:0.012508:0.006821:0.012604:0.006042:0.006831:0.005792:0.003848:0.007466:0.009660:0.006831:0.005713:0.012508:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.006818:0.009621:0.006831:0.005713:0.012508:0.013181:0.011699:0.012450:0.003848:0.011738:0.012950:0.006831:0.006523:0.012604:0.013123:0.013143:0.012450:0.006388
co and alcohol exposure, prevention and :@0.084242:0.549206:0.480507:0.549206:0.480507:0.533450:0.084242:0.533450:0.012450:0.012604:0.005677:0.013143:0.011738:0.013181:0.005677:0.013143:0.003848:0.012450:0.012604:0.011738:0.012604:0.003848:0.005677:0.012508:0.009236:0.013123:0.012604:0.007466:0.011699:0.005711:0.012508:0.005330:0.005677:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.003848:0.012604:0.011738:0.005667:0.013143:0.011738:0.013181:0.005330
management of intercurrent bacterial, vi-:@0.084242:0.565875:0.475148:0.565875:0.475148:0.550119:0.084242:0.550119:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.006148:0.012604:0.006042:0.006158:0.003848:0.011738:0.006523:0.012508:0.005653:0.012450:0.011699:0.005792:0.005705:0.012508:0.011738:0.006523:0.006158:0.013123:0.013143:0.012450:0.006523:0.012508:0.005792:0.003848:0.013143:0.003848:0.005330:0.006158:0.010660:0.003848:0.006388
ral and fungal infections, immune system :@0.084242:0.582544:0.480476:0.582544:0.480476:0.566788:0.084242:0.566788:0.005792:0.013143:0.003848:0.007668:0.013143:0.011738:0.013181:0.007668:0.006042:0.011699:0.011738:0.012950:0.013143:0.003848:0.007664:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.007660:0.003848:0.018049:0.018049:0.011699:0.011738:0.012508:0.007664:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005330
support and dealing with other  general :@0.084242:0.599213:0.480492:0.599213:0.480492:0.583457:0.084242:0.583457:0.007466:0.011699:0.013123:0.013123:0.012604:0.005792:0.006523:0.010314:0.013143:0.011738:0.013181:0.010314:0.013181:0.012508:0.013143:0.003848:0.003848:0.011738:0.012950:0.010314:0.015990:0.003848:0.006523:0.011738:0.010314:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330:0.004974:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.005330
health issues related to  HIV – along with :@0.084242:0.615881:0.480490:0.615881:0.480490:0.600125:0.084242:0.600125:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.008775:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.008775:0.005713:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.008775:0.006523:0.012604:0.005330:0.003435:0.013143:0.004349:0.013508:0.008775:0.009621:0.008775:0.013143:0.003848:0.012604:0.011738:0.012950:0.008775:0.015990:0.003848:0.006523:0.011738:0.005330
appropriate screening, will  be central in :@0.084242:0.632550:0.480478:0.632550:0.480478:0.616794:0.084242:0.616794:0.013143:0.013123:0.013123:0.005719:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508:0.009448:0.007466:0.012450:0.005711:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.005330:0.009448:0.015990:0.003848:0.003848:0.003848:0.005330:0.004133:0.013123:0.012508:0.009448:0.012450:0.012508:0.011738:0.006523:0.005792:0.013143:0.003848:0.009448:0.003848:0.011738:0.005330
dealing with this increase.:@0.084242:0.649219:0.323824:0.649219:0.323824:0.633463:0.084242:0.633463:0.013181:0.012508:0.013143:0.003848:0.003848:0.011738:0.012950:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.006523:0.011738:0.003848:0.007466:0.005330:0.003848:0.011738:0.012450:0.005709:0.012508:0.013143:0.007466:0.012508:0.005330
In  South  Africa,  which  has  the  world’s :@0.102426:0.665888:0.480482:0.665888:0.480482:0.650132:0.102426:0.650132:0.004349:0.011738:0.005330:0.004528:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.004520:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.005330:0.004520:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330:0.004530:0.011738:0.013143:0.007466:0.005330:0.004532:0.006523:0.011738:0.012508:0.005330:0.004522:0.015990:0.012604:0.005792:0.003848:0.013181:0.006754:0.007466:0.005330
highest burden of this disease, the HIV :@0.084242:0.682556:0.480480:0.682556:0.480480:0.666800:0.084242:0.666800:0.011738:0.003848:0.012950:0.011738:0.012508:0.007466:0.006523:0.011796:0.013123:0.011699:0.005675:0.013181:0.012508:0.011738:0.011796:0.012604:0.006042:0.011796:0.006523:0.011738:0.003848:0.007466:0.011796:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.011796:0.006523:0.011738:0.012508:0.011796:0.013143:0.004349:0.013508:0.005330
deaths as a percentage of all deaths has :@0.084242:0.699225:0.480470:0.699225:0.480470:0.683469:0.084242:0.683469:0.013181:0.012508:0.013143:0.006523:0.011738:0.007466:0.006158:0.013143:0.007466:0.006158:0.013143:0.006158:0.013123:0.012508:0.005655:0.012450:0.012508:0.011738:0.006523:0.013143:0.012950:0.012508:0.006148:0.012604:0.006042:0.006158:0.013143:0.003848:0.003848:0.006158:0.013181:0.012508:0.013143:0.006523:0.011738:0.007466:0.006158:0.011738:0.013143:0.007466:0.005330
fallen from  42%  in  2002 to  25% in  2017, :@0.084242:0.715894:0.480470:0.715894:0.480470:0.700138:0.084242:0.700138:0.006042:0.013143:0.003848:0.003848:0.012508:0.011738:0.010506:0.006042:0.005713:0.012604:0.018049:0.005330:0.005161:0.010660:0.010660:0.014913:0.005330:0.005165:0.003848:0.011738:0.005330:0.005167:0.010660:0.010660:0.010660:0.010660:0.010506:0.006523:0.012604:0.005330:0.005157:0.010660:0.010660:0.014913:0.010506:0.003848:0.011738:0.005330:0.005165:0.010660:0.010660:0.010660:0.010660:0.005330:0.005330
while the prevalence of  this disease has :@0.084242:0.732563:0.480494:0.732563:0.480494:0.716807:0.084242:0.716807:0.015990:0.011738:0.003848:0.003848:0.012508:0.008890:0.006523:0.011738:0.012508:0.008890:0.013123:0.005717:0.012508:0.010660:0.013143:0.003848:0.012508:0.011738:0.012450:0.012508:0.008890:0.012604:0.006042:0.005330:0.003550:0.006523:0.011738:0.003848:0.007466:0.008890:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.008890:0.011738:0.013143:0.007466:0.005330
increased  from  just  under  five  million  to :@0.084242:0.749231:0.480488:0.749231:0.480488:0.733475:0.084242:0.733475:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.005330:0.005005:0.006042:0.005711:0.012604:0.018049:0.005330:0.004999:0.003906:0.011699:0.007466:0.006523:0.005330:0.005003:0.011699:0.011738:0.013181:0.012508:0.005792:0.005330:0.004993:0.004686:0.004686:0.010660:0.012508:0.005330:0.004999:0.018049:0.003848:0.003848:0.003848:0.003848:0.012604:0.011738:0.005330:0.005011:0.006523:0.012604:0.005330
seven million over the same period.:@0.084242:0.765900:0.413441:0.765900:0.413441:0.750144:0.084242:0.750144:0.007466:0.012508:0.010660:0.012508:0.011738:0.005330:0.018049:0.003848:0.003848:0.003848:0.003848:0.012604:0.011738:0.005330:0.012604:0.010660:0.012508:0.005792:0.005330:0.006523:0.011738:0.012508:0.005330:0.007466:0.013143:0.018049:0.012508:0.005330:0.013123:0.012508:0.005792:0.003848:0.012604:0.013181:0.005330
17:@0.413421:0.760425:0.425851:0.760425:0.425851:0.751240:0.413421:0.751240:0.006215:0.006215
The impact on the national health-:@0.102424:0.782720:0.475207:0.782720:0.475207:0.766964:0.102424:0.766964:0.008582:0.012123:0.012892:0.012969:0.004233:0.018434:0.013508:0.013527:0.012835:0.006908:0.012969:0.012989:0.012123:0.012969:0.006908:0.012123:0.012892:0.012969:0.012123:0.013527:0.006908:0.004233:0.012989:0.012123:0.013527:0.004233:0.012969:0.012123:0.012892:0.013527:0.004233:0.006908:0.012123:0.006388
care budget of managing HIV-related :@0.084240:0.799097:0.480493:0.799097:0.480493:0.783342:0.084240:0.783342:0.012835:0.013527:0.006096:0.012892:0.011141:0.013508:0.012084:0.013566:0.013335:0.012892:0.006908:0.011141:0.012989:0.006427:0.011141:0.018434:0.013527:0.012123:0.013527:0.013335:0.004233:0.012123:0.013335:0.011141:0.013527:0.004734:0.013893:0.006773:0.006098:0.012892:0.004233:0.013527:0.006908:0.012892:0.013181:0.005330
cancers is high and can be expected to :@0.084240:0.815475:0.480487:0.815475:0.480487:0.799719:0.084240:0.799719:0.012835:0.013527:0.012123:0.012835:0.012892:0.006177:0.007851:0.005721:0.004233:0.007851:0.005723:0.012123:0.004233:0.013335:0.012123:0.005723:0.013527:0.012123:0.013566:0.005723:0.012835:0.013527:0.012123:0.005723:0.013508:0.012892:0.005723:0.012892:0.009621:0.013508:0.012892:0.012835:0.006908:0.012892:0.013566:0.005723:0.006908:0.012598:0.005330
continue to rise.:@0.084240:0.831853:0.238237:0.831853:0.238237:0.816097:0.084240:0.816097:0.012835:0.012989:0.012123:0.006908:0.004233:0.012123:0.012084:0.012892:0.005715:0.006908:0.012989:0.005715:0.006177:0.004233:0.007851:0.012892:0.005330
REFERENCES:@0.084240:0.861671:0.195076:0.861671:0.195076:0.845638:0.084240:0.845638:0.011161:0.010006:0.009236:0.010006:0.011161:0.010006:0.014239:0.015009:0.010006:0.010006
1.:@0.084242:0.878627:0.098456:0.878627:0.098456:0.864621:0.084242:0.864621:0.009476:0.004738
  Hernández-Ramírez RU, Shiels MS, Dubrow:@0.120589:0.878627:0.475154:0.878627:0.475154:0.864621:0.120589:0.864621:0.004738:-0.004738:0.011682:0.011118:0.005504:0.010434:0.011682:0.010434:0.011716:0.011118:0.007269:0.005679:0.010382:0.011682:0.016044:0.003421:0.005075:0.011118:0.007269:0.007201:0.010382:0.011203:0.004738:0.007201:0.008518:0.010434:0.003421:0.011118:0.003421:0.006636:0.007201:0.015719:0.008518:0.004738:0.007201:0.012726:0.010399:0.011665:0.005080:0.011203:0.014214
R, :@0.120589:0.892949:0.140447:0.892949:0.140447:0.878944:0.120589:0.878944:0.010382:0.004738:0.004738
et al:@0.141166:0.892949:0.178641:0.892949:0.178641:0.878944:0.141166:0.878944:0.011118:0.005798:0.005456:0.011682:0.003421
. Cancer risk in HIV-infected people :@0.178641:0.892949:0.479866:0.892949:0.479866:0.878944:0.178641:0.878944:0.004738:0.005456:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.005456:0.005148:0.003421:0.006636:0.008586:0.005456:0.003421:0.010434:0.005456:0.011682:0.003866:0.012007:0.005679:0.003421:0.010434:0.005371:0.011118:0.011067:0.005798:0.011118:0.011716:0.005456:0.011665:0.011118:0.011203:0.011665:0.003421:0.011118:0.004738
in the USA from 1996 to 2012: a population-:@0.120589:0.907272:0.475169:0.907272:0.475169:0.893267:0.120589:0.893267:0.003421:0.010434:0.004687:0.005798:0.010434:0.011118:0.004687:0.011203:0.008518:0.012657:0.004687:0.005371:0.005077:0.011203:0.016044:0.004687:0.009476:0.009476:0.009476:0.009476:0.004687:0.005798:0.011203:0.004687:0.009476:0.009476:0.009476:0.009476:0.004738:0.004697:0.011682:0.004687:0.011665:0.011203:0.011665:0.010399:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.005679
based, registry-linkage  study. :@0.120589:0.921595:0.372336:0.921595:0.372336:0.907590:0.120589:0.907590:0.011665:0.011682:0.006636:0.011118:0.011716:0.004738:0.008638:0.005078:0.011118:0.011511:0.003421:0.006636:0.005798:0.005148:0.009168:0.005679:0.003421:0.003421:0.010434:0.008586:0.011682:0.011511:0.011118:0.004738:0.003890:0.006636:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
Lancet  HIV.:@0.376236:0.921595:0.475154:0.921595:0.475154:0.907590:0.376236:0.907590:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.004738:0.003886:0.011682:0.003866:0.012007:0.004738
 :@0.475154:0.921595:0.479892:0.921595:0.479892:0.907590:0.475154:0.907590:0.004738
2017 Aug 10;pii:S2352-3018(17)30125-X.:@0.120589:0.935918:0.439260:0.935918:0.439260:0.921912:0.120589:0.921912:0.009476:0.009476:0.009476:0.009476:0.004738:0.012657:0.010399:0.011511:0.004738:0.009476:0.009476:0.004738:0.011665:0.003421:0.003421:0.004738:0.008518:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.009476:0.006312:0.009476:0.009476:0.006312:0.009476:0.009476:0.009476:0.009476:0.009476:0.005679:0.010417:0.004738
2.:@0.523636:0.094743:0.537679:0.094743:0.537679:0.080737:0.523636:0.080737:0.009305:0.004738
  Powles  T,  Macdonald  D,  Nelson  M, :@0.559983:0.094743:0.864901:0.094743:0.864901:0.080737:0.559983:0.080737:0.004738:-0.004738:0.009955:0.011032:0.014043:0.003250:0.010947:0.006465:0.004738:0.004413:0.005366:0.004567:0.004738:0.004418:0.015548:0.011511:0.010895:0.011545:0.011032:0.010263:0.011511:0.003250:0.011545:0.004738:0.004418:0.012555:0.004567:0.004738:0.004418:0.012486:0.010947:0.003250:0.006465:0.011032:0.010263:0.004738:0.004418:0.015548:0.004567:0.004738
et  al:@0.869315:0.094743:0.909978:0.094743:0.909978:0.080737:0.869315:0.080737:0.010947:0.005627:0.004738:0.004418:0.011511:0.003421
.:@0.909807:0.094743:0.914544:0.094743:0.914544:0.080737:0.909807:0.080737:0.004738
Hepatocellular cancer in HIV-infected indi-:@0.559983:0.109759:0.914556:0.109759:0.914556:0.095754:0.559983:0.095754:0.011511:0.010947:0.011494:0.011511:0.005627:0.011032:0.010895:0.010947:0.003250:0.003250:0.010228:0.003250:0.011511:0.004977:0.006483:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.006483:0.003250:0.010263:0.006483:0.011511:0.003695:0.011836:0.005508:0.003250:0.010263:0.005200:0.010947:0.010895:0.005627:0.010947:0.011545:0.006483:0.003250:0.010263:0.011545:0.003250:0.005679
viduals: tomorrow’s problem? :@0.559983:0.124776:0.802468:0.124776:0.802468:0.110770:0.559983:0.110770:0.009305:0.003250:0.011545:0.010228:0.011511:0.003250:0.006465:0.004567:0.003934:0.005627:0.011032:0.015873:0.011032:0.004977:0.004907:0.011032:0.014043:0.005833:0.006465:0.003934:0.011494:0.004907:0.011032:0.011494:0.003250:0.010947:0.015873:0.009938:0.004738
Expert Review:@0.801664:0.124776:0.914553:0.124776:0.914553:0.110770:0.801664:0.110770:0.008997:0.008039:0.011494:0.010947:0.004977:0.005627:0.003934:0.010211:0.010947:0.009305:0.003250:0.010947:0.014214
of Anticancer Therapy.:@0.559983:0.139792:0.769289:0.139792:0.769289:0.125787:0.559983:0.125787:0.011032:0.005200:0.015958:0.012486:0.010263:0.005627:0.003250:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.015958:0.007115:0.010263:0.010947:0.004977:0.011511:0.011494:0.008997:0.004738
 2006;6(11):1553-:@0.769118:0.139792:0.914522:0.139792:0.914522:0.125787:0.769118:0.125787:0.015958:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.006140:0.009305:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.009305:0.005679
1558.:@0.559983:0.154809:0.601940:0.154809:0.601940:0.140804:0.559983:0.140804:0.009305:0.009305:0.009305:0.009305:0.004738
3. :@0.523636:0.169825:0.542246:0.169825:0.542246:0.155820:0.523636:0.155820:0.009305:0.004567:0.004738
  Angeletti PC, Zhang L, Wood C. The viral eti-:@0.559983:0.169825:0.914625:0.169825:0.914625:0.155820:0.559983:0.155820:0.004738:-0.004738:0.012486:0.010263:0.011340:0.010947:0.003250:0.010947:0.005627:0.005627:0.003250:0.004430:0.009955:0.013735:0.004567:0.004430:0.008039:0.010263:0.011511:0.010263:0.011340:0.004430:0.007731:0.004567:0.004430:0.015462:0.011032:0.011032:0.011545:0.004430:0.013735:0.004567:0.004430:0.007115:0.010263:0.010947:0.004430:0.009305:0.003250:0.004977:0.011511:0.003250:0.004430:0.010947:0.005627:0.003250:0.005679
ology of AIDS-associated malignancies. :@0.559983:0.184842:0.885139:0.184842:0.885139:0.170837:0.559983:0.170837:0.011032:0.003250:0.011032:0.011340:0.008997:0.004437:0.011032:0.005200:0.004435:0.012486:0.003695:0.012555:0.008347:0.005508:0.011511:0.006465:0.006465:0.011032:0.010895:0.003250:0.011511:0.005627:0.010947:0.011545:0.004437:0.015873:0.011511:0.003250:0.003250:0.011340:0.010263:0.011511:0.010263:0.010895:0.003250:0.010947:0.006465:0.004567:0.004738
Ad-:@0.884829:0.184842:0.914539:0.184842:0.914539:0.170837:0.884829:0.170837:0.012486:0.011545:0.005679
vances in Pharmacology.:@0.559983:0.199859:0.767391:0.199859:0.767391:0.185853:0.559983:0.185853:0.009305:0.011511:0.010263:0.010895:0.010947:0.006465:0.004567:0.003250:0.010263:0.004567:0.009955:0.010263:0.011511:0.004977:0.015873:0.011511:0.010895:0.011032:0.003250:0.011032:0.011340:0.008997:0.004738
 2008;56:509-557.:@0.767219:0.199859:0.902823:0.199859:0.902823:0.185853:0.767219:0.185853:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.004738
4.:@0.523636:0.214875:0.537679:0.214875:0.537679:0.200870:0.523636:0.200870:0.009305:0.004738
  Silverberg  MJ,  Abrams  DI.  AIDS-defining:@0.559983:0.214875:0.914556:0.214875:0.914556:0.200870:0.559983:0.200870:0.004738:-0.004738:0.008347:0.003250:0.003250:0.009305:0.010947:0.004977:0.011494:0.010947:0.004994:0.011340:0.004738:0.009108:0.015548:0.008073:0.004567:0.004738:0.009108:0.012486:0.011494:0.004977:0.011511:0.015873:0.006465:0.004738:0.009108:0.012555:0.003695:0.004567:0.004738:0.009108:0.012486:0.003695:0.012555:0.008347:0.005508:0.011545:0.010947:0.004079:0.004079:0.010263:0.003250:0.010263:0.011511
and :@0.559983:0.229892:0.598040:0.229892:0.598040:0.215886:0.559983:0.215886:0.011511:0.010263:0.011545:0.004738
non-AIDS-defining :@0.624441:0.229892:0.774600:0.229892:0.774600:0.215886:0.624441:0.215886:0.010263:0.011032:0.010263:0.005508:0.012486:0.003695:0.012555:0.008347:0.005508:0.011545:0.010947:0.004079:0.004079:0.010263:0.003250:0.010263:0.011340:0.004738
malignancies: :@0.800999:0.229892:0.919289:0.229892:0.919289:0.215886:0.800999:0.215886:0.015873:0.011511:0.003250:0.003250:0.011340:0.010263:0.011511:0.010263:0.010895:0.003250:0.010947:0.006465:0.004734:0.004738
cancer occurrence in the antiretroviral :@0.559983:0.244908:0.919310:0.244908:0.919310:0.230903:0.559983:0.230903:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.014556:0.011032:0.010895:0.010895:0.010228:0.004977:0.004907:0.010947:0.010263:0.010895:0.010947:0.014556:0.003250:0.010263:0.014556:0.005627:0.010263:0.010947:0.014556:0.011511:0.010263:0.005627:0.003250:0.004907:0.010947:0.005627:0.004907:0.011032:0.009305:0.003250:0.004977:0.011511:0.003424:0.004738
therapy era.:@0.559983:0.259925:0.662780:0.259925:0.662780:0.245920:0.559983:0.245920:0.005627:0.010263:0.010947:0.004977:0.011511:0.011494:0.008997:0.006808:0.010947:0.004977:0.011511:0.004738
 Current Opinion in Oncology.:@0.662609:0.259925:0.914591:0.259925:0.914591:0.245920:0.662609:0.245920:0.006808:0.013735:0.010228:0.004977:0.004977:0.010947:0.010263:0.005627:0.006808:0.014693:0.011494:0.003250:0.010263:0.003250:0.011032:0.010263:0.006808:0.003250:0.010263:0.006808:0.014693:0.010263:0.010895:0.011032:0.003250:0.011032:0.011340:0.008997:0.004738
 :@0.914539:0.259925:0.919277:0.259925:0.919277:0.245920:0.914539:0.245920:0.004738
2007;19(5):446-451.:@0.559983:0.274941:0.712605:0.274941:0.712605:0.260936:0.559983:0.260936:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.006140:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.004738
5.:@0.523636:0.289958:0.537679:0.289958:0.537679:0.275953:0.523636:0.275953:0.009305:0.004738
  Grogg KL, Miller RF, Dogan A. HIV infection:@0.559983:0.289958:0.914570:0.289958:0.914570:0.275953:0.559983:0.275953:0.004738:-0.004738:0.014744:0.004909:0.011032:0.011340:0.011340:0.006465:0.009938:0.007731:0.004567:0.006465:0.015548:0.003250:0.003250:0.003250:0.010947:0.004977:0.006465:0.010211:0.006034:0.004567:0.006465:0.012555:0.011032:0.011340:0.011511:0.010263:0.006465:0.012486:0.004567:0.006465:0.011511:0.003695:0.011836:0.006465:0.003250:0.010263:0.005200:0.010947:0.010895:0.005627:0.003250:0.011032:0.010434
and lymphoma. :@0.559983:0.304975:0.698118:0.304975:0.698118:0.290969:0.559983:0.290969:0.011511:0.010263:0.011545:0.007218:0.003250:0.008997:0.015873:0.011494:0.010263:0.011032:0.015873:0.011511:0.004567:0.004738
Journal of Clinical Pathol-:@0.700598:0.304975:0.914539:0.304975:0.914539:0.290969:0.700598:0.290969:0.008073:0.011032:0.010228:0.004977:0.010263:0.011511:0.003250:0.007218:0.011032:0.005200:0.007218:0.013735:0.003250:0.003250:0.010263:0.003250:0.010895:0.011511:0.003250:0.007218:0.009955:0.011511:0.005627:0.010263:0.011032:0.003250:0.005679
ogy.:@0.559983:0.319991:0.596090:0.319991:0.596090:0.305986:0.559983:0.305986:0.011032:0.011340:0.008997:0.004738
 2007;60(12):1365-1372.:@0.595919:0.319991:0.781023:0.319991:0.781023:0.305986:0.595919:0.305986:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.006140:0.009305:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.009305:0.004738
6.:@0.523636:0.335008:0.537679:0.335008:0.537679:0.321002:0.523636:0.321002:0.009305:0.004738
  Levine AM. AIDS-related malignancies. :@0.559983:0.335008:0.880023:0.335008:0.880023:0.321002:0.559983:0.321002:0.004738:-0.004738:0.007731:0.010947:0.009305:0.003250:0.010263:0.010947:0.005183:0.012486:0.015548:0.004567:0.005183:0.012486:0.003695:0.012555:0.008347:0.005508:0.004909:0.010947:0.003250:0.011511:0.005627:0.010947:0.011545:0.005183:0.015873:0.011511:0.003250:0.003250:0.011340:0.010263:0.011511:0.010263:0.010895:0.003250:0.010947:0.006465:0.004567:0.004738
Curr:@0.880467:0.335008:0.914556:0.335008:0.914556:0.321002:0.880467:0.321002:0.013735:0.010228:0.004977:0.005148
Opin Oncol.:@0.559983:0.350024:0.659120:0.350024:0.659120:0.336019:0.559983:0.336019:0.014693:0.011494:0.003250:0.010263:0.004567:0.014693:0.010263:0.010895:0.011032:0.003250:0.004738
 1994;6:489.:@0.658949:0.350024:0.751826:0.350024:0.751826:0.336019:0.658949:0.336019:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.004567:0.009305:0.009305:0.009305:0.004738
7.:@0.523636:0.365041:0.537679:0.365041:0.537679:0.351036:0.523636:0.351036:0.009305:0.004738
  Besson  C,  Lancar  R,  Prevot  S, :@0.559983:0.365041:0.819802:0.365041:0.819802:0.351036:0.559983:0.351036:0.004738:-0.004738:0.009647:0.010947:0.006465:0.006465:0.011032:0.010263:0.004738:0.004379:0.013735:0.004567:0.004738:0.004396:0.007731:0.011511:0.010263:0.010895:0.011511:0.004977:0.004738:0.004384:0.010211:0.004567:0.004738:0.004374:0.009955:0.004907:0.010947:0.009305:0.011032:0.005627:0.004738:0.004384:0.008347:0.004567:0.004738
et  al:@0.824177:0.365041:0.864805:0.365041:0.864805:0.351036:0.824177:0.351036:0.010947:0.005627:0.004738:0.004384:0.011511:0.003421
.  Out-:@0.864634:0.365041:0.914550:0.365041:0.914550:0.351036:0.864634:0.351036:0.004567:0.004738:0.004384:0.014693:0.010228:0.005627:0.005679
comes for HIV-associated diffuse large :@0.559983:0.380057:0.919270:0.380057:0.919270:0.366052:0.559983:0.366052:0.010895:0.011032:0.015873:0.010947:0.006465:0.015308:0.005200:0.011032:0.004977:0.015308:0.011511:0.003695:0.011836:0.005508:0.011511:0.006465:0.006465:0.011032:0.010895:0.003250:0.011511:0.005627:0.010947:0.011545:0.015308:0.011545:0.003250:0.005249:0.005200:0.010228:0.006465:0.010947:0.015308:0.003250:0.011511:0.004991:0.011340:0.011116:0.004738
B-cell lymphoma in the modern com-:@0.559983:0.395074:0.914570:0.395074:0.914570:0.381069:0.559983:0.381069:0.009647:0.005508:0.010895:0.010947:0.003250:0.003250:0.014795:0.003250:0.008997:0.015873:0.011494:0.010263:0.011032:0.015873:0.011511:0.014795:0.003250:0.010263:0.014795:0.005627:0.010263:0.010947:0.014795:0.015873:0.011032:0.011545:0.010947:0.005333:0.010263:0.014795:0.010895:0.011032:0.015873:0.005679
bined antiretroviral therapy era. :@0.559983:0.410091:0.827490:0.410091:0.827490:0.396085:0.559983:0.396085:0.011494:0.003250:0.010263:0.010947:0.011545:0.006363:0.011511:0.010263:0.005627:0.003250:0.004906:0.010947:0.005627:0.004907:0.011032:0.009305:0.003250:0.004977:0.011511:0.003250:0.006363:0.005627:0.010263:0.010947:0.004977:0.011511:0.011494:0.008997:0.006363:0.010947:0.004977:0.011511:0.004567:0.004738
AIDS.:@0.829115:0.410091:0.870935:0.410091:0.870935:0.396085:0.829115:0.396085:0.012486:0.003695:0.012555:0.008347:0.004738
 2017 :@0.870764:0.410091:0.919258:0.410091:0.919258:0.396085:0.870764:0.396085:0.006363:0.009305:0.009305:0.009305:0.009479:0.004738
Nov 28;31(18):2493-2501. Doi: 10.1097/:@0.559983:0.425107:0.914488:0.425107:0.914488:0.411102:0.559983:0.411102:0.012486:0.011032:0.009305:0.020217:0.009305:0.009305:0.004567:0.009305:0.009305:0.006140:0.009305:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.009305:0.004567:0.020217:0.012555:0.011032:0.003250:0.004567:0.020217:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.009305:0.007475
QAD.0000000001652.:@0.559983:0.440124:0.730018:0.440124:0.730018:0.426118:0.559983:0.426118:0.014727:0.012486:0.012555:0.004567:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.004738
8.:@0.523636:0.455140:0.537679:0.455140:0.537679:0.441135:0.523636:0.441135:0.009305:0.004738
  Jacobson CA, Abrahamson JS. Review ar-:@0.559983:0.455140:0.914591:0.455140:0.914591:0.441135:0.559983:0.441135:0.004738:-0.004738:0.008073:0.011511:0.010895:0.011032:0.011494:0.006465:0.011032:0.010263:0.007064:0.013735:0.012486:0.004567:0.007064:0.012486:0.011494:0.004977:0.011511:0.010263:0.011511:0.015873:0.006465:0.011032:0.010263:0.007064:0.008073:0.008347:0.004567:0.007064:0.010211:0.010947:0.009305:0.003250:0.010947:0.014043:0.007064:0.011511:0.004977:0.005679
ticle. HIV-associated Hodgkin’s lymphoma: :@0.559983:0.470157:0.919265:0.470157:0.919265:0.456152:0.559983:0.456152:0.005627:0.003250:0.010895:0.003250:0.010947:0.004567:0.007175:0.011511:0.003695:0.011836:0.005508:0.011511:0.006465:0.006465:0.011032:0.010895:0.003250:0.011511:0.005627:0.010947:0.011545:0.007175:0.011511:0.011032:0.011545:0.011340:0.008415:0.003250:0.010263:0.005833:0.006465:0.007175:0.003250:0.008997:0.015873:0.011494:0.010263:0.011032:0.015873:0.011511:0.004734:0.004738
prognosis  and  therapy  in  the  era  of  cART. :@0.559983:0.485173:0.919305:0.485173:0.919305:0.471168:0.559983:0.471168:0.011494:0.004907:0.011032:0.011340:0.010263:0.011032:0.006465:0.003250:0.006465:0.004738:0.002812:0.011511:0.010263:0.011545:0.004738:0.002814:0.005627:0.010263:0.010947:0.004977:0.011511:0.011494:0.008997:0.004738:0.002812:0.003250:0.010263:0.004738:0.002812:0.005627:0.010263:0.010947:0.004738:0.002812:0.010947:0.004977:0.011511:0.004738:0.002814:0.011032:0.005200:0.004738:0.002814:0.010895:0.012486:0.010309:0.005901:0.004736:0.004738
Advances in Hematology:@0.559983:0.500190:0.779894:0.500190:0.779894:0.486185:0.559983:0.486185:0.012486:0.011545:0.009305:0.011511:0.010263:0.010895:0.010947:0.006465:0.010844:0.003250:0.010263:0.010844:0.011511:0.010947:0.015873:0.011511:0.005627:0.011032:0.003250:0.011032:0.011340:0.009168
. 2012(4):507257 :@0.779723:0.500190:0.919246:0.500190:0.919246:0.486185:0.779723:0.486185:0.004567:0.010844:0.009305:0.009305:0.009305:0.009305:0.006140:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.009305:0.009305:0.009479:0.004738
http://dx.doi.org/10.1155/2012/507257.:@0.559983:0.515207:0.874170:0.515207:0.874170:0.501201:0.559983:0.501201:0.010263:0.005627:0.005627:0.011494:0.004567:0.007304:0.007304:0.011545:0.008039:0.004567:0.011545:0.011032:0.003250:0.004567:0.011032:0.004991:0.011340:0.007304:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.009305:0.007304:0.009305:0.009305:0.009305:0.009305:0.007304:0.009305:0.009305:0.009305:0.009305:0.009305:0.009305:0.004738
9.:@0.523636:0.530223:0.537679:0.530223:0.537679:0.516218:0.523636:0.516218:0.009305:0.004738
  Dryden-Peterson  S,  Bvochora-Nsingo  M,:@0.559983:0.530223:0.914570:0.530223:0.914570:0.516218:0.559983:0.516218:0.004738:-0.004738:0.012555:0.004977:0.008997:0.011545:0.010947:0.010263:0.005508:0.009955:0.010947:0.005627:0.010947:0.004977:0.006465:0.011032:0.010263:0.004738:0.011049:0.008347:0.004567:0.004738:0.011056:0.009647:0.009305:0.011032:0.010895:0.010263:0.011032:0.004977:0.011511:0.005508:0.012486:0.006465:0.003250:0.010263:0.011340:0.011032:0.004738:0.011056:0.015548:0.004738
Suneja G, :@0.559983:0.545240:0.646514:0.545240:0.646514:0.531235:0.559983:0.531235:0.008347:0.010228:0.010263:0.010947:0.003301:0.011511:0.007885:0.014744:0.004567:0.004738
et al:@0.649661:0.545240:0.689053:0.545240:0.689053:0.531235:0.649661:0.531235:0.010947:0.005627:0.007885:0.011511:0.003421
. HIV infection and survival :@0.688882:0.545240:0.919281:0.545240:0.919281:0.531235:0.688882:0.531235:0.004567:0.007885:0.011511:0.003695:0.011836:0.007885:0.003250:0.010263:0.005200:0.010947:0.010895:0.005627:0.003250:0.011032:0.010263:0.007885:0.011511:0.010263:0.011545:0.007885:0.006465:0.010228:0.004977:0.009305:0.003250:0.009305:0.011511:0.003424:0.004738
among women with cervical cancer:@0.559983:0.560256:0.860968:0.560256:0.860968:0.546251:0.559983:0.546251:0.011511:0.015873:0.011032:0.010263:0.011340:0.005234:0.014043:0.011032:0.015873:0.010947:0.010263:0.005234:0.014043:0.003250:0.005627:0.010263:0.005234:0.010895:0.010947:0.004977:0.009305:0.003250:0.010895:0.011511:0.003250:0.005234:0.010895:0.011511:0.010263:0.010895:0.010947:0.005148
. J Clin :@0.860797:0.560256:0.919308:0.560256:0.919308:0.546251:0.860797:0.546251:0.004567:0.005234:0.008073:0.005234:0.013735:0.003250:0.003250:0.010430:0.004738
Oncol:@0.559983:0.575273:0.610287:0.575273:0.610287:0.561268:0.559983:0.561268:0.014693:0.010263:0.010895:0.011032:0.003421
. 2016 Nov 1;34(31):3749-3757.:@0.610116:0.575273:0.851099:0.575273:0.851099:0.561268:0.610116:0.561268:0.004567:0.004567:0.009305:0.009305:0.009305:0.009476:0.004447:0.012486:0.011032:0.009305:0.004567:0.009305:0.004567:0.009305:0.009305:0.006140:0.009305:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.009305:0.009305:0.004738
 :@0.656469:0.575273:0.661258:0.575273:0.661258:0.561021:0.656469:0.561021:0.004789
10.  Singh E, Naidu G, Davies MA, :@0.523636:0.590289:0.797323:0.590289:0.797323:0.576284:0.523636:0.576284:0.009305:0.009305:0.004738:0.012999:0.000000:0.008347:0.003250:0.010263:0.011340:0.010263:0.004122:0.008997:0.004567:0.004122:0.012486:0.011511:0.003250:0.011545:0.010228:0.004122:0.014744:0.004567:0.004122:0.012555:0.011511:0.009305:0.003250:0.010947:0.006465:0.004122:0.015548:0.012486:0.004567:-0.176272
et al.:@0.796707:0.590289:0.836903:0.590289:0.836903:0.576284:0.796707:0.576284:0.010947:0.005627:0.004122:0.011511:0.003250:0.004738
 HIV-asso-:@0.836732:0.590289:0.914556:0.590289:0.914556:0.576284:0.836732:0.576284:0.004122:0.011511:0.003695:0.011836:0.005508:0.011511:0.006465:0.006465:0.011032:0.005679
ciated malignancies in children.:@0.559983:0.605306:0.827032:0.605306:0.827032:0.591301:0.559983:0.591301:0.010895:0.003250:0.011511:0.005627:0.010947:0.011545:0.006961:0.015873:0.011511:0.003250:0.003250:0.011340:0.010263:0.011511:0.010263:0.010895:0.003250:0.010947:0.006465:0.006961:0.003250:0.010263:0.006961:0.010895:0.010263:0.003250:0.003250:0.011545:0.004907:0.010947:0.010263:0.004738
 Curr Opin :@0.826861:0.605306:0.919306:0.605306:0.919306:0.591301:0.826861:0.591301:0.006961:0.013735:0.010228:0.004977:0.004977:0.006961:0.014693:0.011494:0.003250:0.010430:0.004738
HIV AIDS. :@0.559983:0.620323:0.637979:0.620323:0.637979:0.606317:0.559983:0.606317:0.011511:0.003695:0.011836:0.004567:0.012486:0.003695:0.012555:0.008347:0.004567:0.004738
2017;12:77.:@0.637808:0.620323:0.726118:0.620323:0.726118:0.606317:0.637808:0.606317:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.004738
11.  Deeken JF, Tjen-A-Looi A, Rudek MA, :@0.523636:0.635339:0.869914:0.635339:0.869914:0.621334:0.523636:0.621334:0.009305:0.009305:0.004738:0.012999:0.000000:0.012555:0.010947:0.010947:0.008415:0.010947:0.010263:0.006654:0.008073:0.006038:0.004567:0.006654:0.007115:0.003301:0.010947:0.010263:0.005508:0.012486:0.005508:0.007731:0.011032:0.011032:0.003250:0.006654:0.012486:0.004567:0.006654:0.010211:0.010228:0.011545:0.010947:0.008415:0.006654:0.015548:0.012486:0.004567:0.004738
et al:@0.871830:0.635339:0.909990:0.635339:0.909990:0.621334:0.871830:0.621334:0.010947:0.005627:0.006654:0.011511:0.003421
.:@0.909819:0.635339:0.914556:0.635339:0.914556:0.621334:0.909819:0.621334:0.004738
The  rising  challenge  of  non-AIDS-defining :@0.559983:0.650356:0.919308:0.650356:0.919308:0.636351:0.559983:0.636351:0.007115:0.010263:0.010947:0.004738:0.005821:0.004977:0.003250:0.006465:0.003250:0.010263:0.011340:0.004738:0.005819:0.010895:0.010263:0.011511:0.003250:0.003250:0.010947:0.010263:0.011340:0.010947:0.004738:0.005819:0.011032:0.005200:0.004738:0.005821:0.010263:0.011032:0.010263:0.005508:0.012486:0.003695:0.012555:0.008347:0.005508:0.011545:0.010947:0.004079:0.004079:0.010263:0.003250:0.010263:0.011508:0.004738
cancers in HIV-infected patients. :@0.559983:0.665372:0.831275:0.665372:0.831275:0.651367:0.559983:0.651367:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.006465:0.005371:0.003250:0.010263:0.005371:0.011511:0.003695:0.011836:0.005508:0.003250:0.010263:0.005200:0.010947:0.010895:0.005627:0.010947:0.011545:0.005371:0.011494:0.011511:0.005627:0.003250:0.010947:0.010263:0.005627:0.006465:0.004567:0.004738
Clin Infect :@0.831908:0.665372:0.919310:0.665372:0.919310:0.651367:0.831908:0.651367:0.013735:0.003250:0.003250:0.010263:0.005371:0.003695:0.010263:0.005200:0.010947:0.010895:0.005797:0.004738
Dis.:@0.559983:0.680389:0.586991:0.680389:0.586991:0.666384:0.559983:0.666384:0.012555:0.003250:0.006465:0.004738
 2012;55:1228.:@0.586820:0.680389:0.698306:0.680389:0.698306:0.666384:0.586820:0.666384:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.009305:0.004738
12.  Shiels MS, Althoff KN, Pfeiffer RM, :@0.523636:0.695406:0.835806:0.695406:0.835806:0.681400:0.523636:0.681400:0.009305:0.009305:0.004738:0.012999:0.000000:0.008347:0.010263:0.003250:0.010947:0.003250:0.006465:0.006790:0.015548:0.008347:0.004567:0.006790:0.012486:0.003250:0.005627:0.010263:0.011032:0.005251:0.005200:0.006790:0.009938:0.012486:0.004567:0.006790:0.009955:0.005200:0.010947:0.003250:0.005249:0.005200:0.010947:0.004977:0.006790:0.010211:0.015548:0.004567:-0.367651
et al:@0.837859:0.695406:0.876155:0.695406:0.876155:0.681400:0.837859:0.681400:0.010947:0.005627:0.006790:0.011511:0.003421
. HIV:@0.875984:0.695406:0.914555:0.695406:0.914555:0.681400:0.875984:0.681400:0.004567:0.006790:0.011511:0.003695:0.012007
infection, immunosuppression and age at :@0.559983:0.710422:0.919272:0.710422:0.919272:0.696417:0.559983:0.696417:0.003250:0.010263:0.005200:0.010947:0.010895:0.005627:0.003250:0.011032:0.010263:0.004567:0.008826:0.003250:0.015873:0.015873:0.010228:0.010263:0.011032:0.006465:0.010228:0.011494:0.011494:0.004907:0.010947:0.006465:0.006465:0.003250:0.011032:0.010263:0.008826:0.011511:0.010263:0.011545:0.008826:0.011511:0.011340:0.010947:0.008826:0.011511:0.005795:0.004738
diagnosis of non-aids-defining cancers. :@0.559983:0.725439:0.883389:0.725439:0.883389:0.711433:0.559983:0.711433:0.011545:0.003250:0.011511:0.011340:0.010263:0.011032:0.006465:0.003250:0.006465:0.005227:0.011032:0.005200:0.005227:0.010263:0.011032:0.010263:0.005508:0.011511:0.003250:0.011545:0.006465:0.005508:0.011545:0.010947:0.004079:0.004079:0.010263:0.003250:0.010263:0.011340:0.005227:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.006465:0.004567:0.004738
Clin :@0.883871:0.725439:0.919274:0.725439:0.919274:0.711433:0.883871:0.711433:0.013735:0.003250:0.003250:0.010430:0.004738
Infect Dis.:@0.559983:0.740455:0.638184:0.740455:0.638184:0.726450:0.559983:0.726450:0.003695:0.010263:0.005200:0.010947:0.010895:0.005627:0.004567:0.012555:0.003250:0.006465:0.004738
 2017;64:468.:@0.638013:0.740455:0.740195:0.740455:0.740195:0.726450:0.638013:0.726450:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.004738
13.  Ghebre RG, Grover S, Xu MJ, :@0.523636:0.755472:0.812835:0.755472:0.812835:0.741467:0.523636:0.741467:0.009305:0.009305:0.004738:0.012999:0.000000:0.014744:0.010263:0.010947:0.011494:0.004909:0.010947:0.007560:0.010211:0.014744:0.004567:0.007560:0.014744:0.004907:0.011032:0.009305:0.010947:0.004977:0.007560:0.008347:0.004567:0.007560:0.010246:0.010228:0.007560:0.015548:0.008073:0.004567:-0.432049
et al:@0.815657:0.755472:0.854724:0.755472:0.854724:0.741467:0.815657:0.741467:0.010947:0.005627:0.007560:0.011511:0.003421
. Cervi-:@0.854553:0.755472:0.914572:0.755472:0.914572:0.741467:0.854553:0.741467:0.004567:0.007560:0.013735:0.010947:0.004977:0.009305:0.003250:0.005679
cal cancer control in HIV-infected women: :@0.559983:0.770488:0.919288:0.770488:0.919288:0.756483:0.559983:0.756483:0.010895:0.011511:0.003250:0.006158:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.006158:0.010895:0.011032:0.010263:0.005627:0.004906:0.011032:0.003250:0.006158:0.003250:0.010263:0.006158:0.011511:0.003695:0.011836:0.005508:0.003250:0.010263:0.005200:0.010947:0.010895:0.005627:0.010947:0.011545:0.006158:0.014043:0.011032:0.015873:0.010947:0.010263:0.004734:0.004738
past, present and future. :@0.559983:0.785505:0.779360:0.785505:0.779360:0.771500:0.559983:0.771500:0.011494:0.011511:0.006465:0.005627:0.004567:0.009767:0.011494:0.004907:0.010947:0.006465:0.010947:0.010263:0.005627:0.009767:0.011511:0.010263:0.011545:0.009767:0.005200:0.010228:0.005627:0.010228:0.004907:0.010947:0.004567:0.004738
Gynecol Oncol :@0.784389:0.785505:0.919329:0.785505:0.919329:0.771500:0.784389:0.771500:0.014744:0.008997:0.010263:0.010947:0.010895:0.011032:0.003250:0.009767:0.014693:0.010263:0.010895:0.011032:0.003424:0.004738
Rep.:@0.559983:0.800522:0.597373:0.800522:0.597373:0.786516:0.559983:0.786516:0.010211:0.010947:0.011494:0.004738
 2017;21:101–108. Published online 2017 :@0.597202:0.800522:0.919246:0.800522:0.919246:0.786516:0.597202:0.786516:0.004943:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.008381:0.009305:0.009305:0.009305:0.004567:0.004943:0.009955:0.010228:0.011494:0.003250:0.003250:0.006465:0.010263:0.010947:0.011545:0.004943:0.011032:0.010263:0.003250:0.003250:0.010263:0.010947:0.004943:0.009305:0.009305:0.009305:0.009479:0.004738
Jul 21. Doi:  10.1016/j.gore.2017.07.009.:@0.559983:0.815538:0.870357:0.815538:0.870357:0.801533:0.559983:0.801533:0.008073:0.010228:0.003250:0.004567:0.009305:0.009305:0.004567:0.004567:0.012555:0.011032:0.003250:0.004567:0.004567:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.009305:0.007304:0.003301:0.004567:0.011340:0.011032:0.004907:0.010947:0.004567:0.009305:0.009305:0.009305:0.009305:0.004567:0.009305:0.009305:0.004567:0.009305:0.009305:0.009305:0.004738
14.   National Cancer Institute Factsheet 2011::@0.523636:0.830555:0.914539:0.830555:0.914539:0.816549:0.523636:0.816549:0.009305:0.009305:0.004738:0.012999:0.004738:-0.004738:0.012486:0.011511:0.005627:0.003250:0.011032:0.010263:0.011511:0.003250:0.009801:0.013735:0.011511:0.010263:0.010895:0.010947:0.004977:0.009801:0.003695:0.010263:0.006465:0.005627:0.003250:0.005627:0.010228:0.005627:0.010947:0.009801:0.008125:0.011511:0.010895:0.005627:0.006465:0.010263:0.010947:0.010947:0.005627:0.009801:0.009305:0.009305:0.009305:0.009305:-0.642964
HIV and cancer risk.  http://www.cancer.:@0.559983:0.845571:0.914582:0.845571:0.914582:0.831566:0.559983:0.831566:0.011511:0.003695:0.011836:0.011306:0.011511:0.010263:0.011545:0.011306:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.011306:0.004977:0.003250:0.006465:0.008415:0.004567:0.004738:0.006568:0.010263:0.005627:0.005627:0.011494:0.004567:0.007304:0.007304:0.014043:0.014043:0.014043:0.004567:0.010895:0.011511:0.010263:0.010895:0.010947:0.003720:0.004738
gov/cancertopics/factsheet/Risk/hiv-infec-:@0.559983:0.860588:0.909511:0.860588:0.909511:0.846583:0.559983:0.846583:0.011340:0.011032:0.009305:0.007304:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.005627:0.011032:0.011494:0.003250:0.010895:0.006465:0.007304:0.005200:0.011511:0.010895:0.005627:0.006465:0.010263:0.010947:0.010947:0.005627:0.007304:0.010211:0.003250:0.006465:0.008415:0.007304:0.010263:0.003250:0.009305:0.005508:0.003250:0.010263:0.005200:0.010947:0.010895:0.005679
tion.:@0.559983:0.875604:0.594893:0.875604:0.594893:0.861599:0.559983:0.861599:0.005627:0.003250:0.011032:0.010263:0.004738
15.  Sitas F,  Pacella-Norman R,  Carrara H,:@0.523636:0.890621:0.887241:0.890621:0.887241:0.876616:0.523636:0.876616:0.009305:0.009305:0.004738:0.012999:0.000000:0.008347:0.003250:0.005627:0.011511:0.006465:0.010759:0.006038:0.004567:0.004738:0.006021:0.009955:0.011511:0.010895:0.010947:0.003250:0.003250:0.011511:0.005508:0.012486:0.011032:0.005456:0.015873:0.011511:0.010263:0.010759:0.010211:0.004567:0.004738:0.006004:0.013735:0.011511:0.004977:0.004977:0.011511:0.004977:0.011511:0.010759:0.011511:-0.703035
 et:@0.887053:0.890621:0.914556:0.890621:0.914556:0.876616:0.887053:0.876616:0.010759:0.010947:0.005798
al:@0.559983:0.905638:0.574915:0.905638:0.574915:0.891632:0.559983:0.891632:0.011511:0.003421
.  The  spectrum  of  HIV-1  related  cancers :@0.574744:0.905638:0.919296:0.905638:0.919296:0.891632:0.574744:0.891632:0.004567:0.004738:0.003173:0.007115:0.010263:0.010947:0.004738:0.003173:0.006465:0.011494:0.010947:0.010895:0.005627:0.004977:0.010228:0.015873:0.004738:0.003173:0.011032:0.005200:0.004738:0.003173:0.011511:0.003695:0.011836:0.005508:0.009305:0.004738:0.003173:0.004907:0.010947:0.003250:0.011511:0.005627:0.010947:0.011545:0.004738:0.003173:0.010895:0.011511:0.010263:0.010895:0.010947:0.004977:0.006640:0.004738
in South Africa. :@0.559983:0.920654:0.698888:0.920654:0.698888:0.906649:0.559983:0.906649:0.003250:0.010263:0.011135:0.008347:0.011032:0.010228:0.005627:0.010263:0.011135:0.012486:0.005200:0.004977:0.003250:0.010895:0.011511:0.004567:0.004738
Int J Cancer.:@0.705285:0.920654:0.822278:0.920654:0.822278:0.906649:0.705285:0.906649:0.003695:0.010263:0.005627:0.011135:0.008073:0.011135:0.013735:0.011511:0.010263:0.010895:0.010947:0.004977:0.004738
 2000 Nov :@0.822107:0.920654:0.919332:0.920654:0.919332:0.906649:0.822107:0.906649:0.011135:0.009305:0.009305:0.009305:0.009305:0.011135:0.012486:0.011032:0.009479:0.004738
1;88(3):489-92.:@0.559983:0.935671:0.675386:0.935671:0.675386:0.921665:0.559983:0.921665:0.009305:0.004567:0.009305:0.009305:0.006140:0.009305:0.006140:0.004567:0.009305:0.009305:0.009305:0.005508:0.009305:0.009305:0.004738